Research ArticleArticle
Preclinical Pharmacokinetics of a HepDirect Prodrug of a Novel Phosphonate-Containing Thyroid Hormone Receptor Agonist
James M. Fujitaki, Edward E. Cable, Bruce R. Ito, Bao-Hong Zhang, Jinzhao Hou, Chun Yang, David A. Bullough, James L. Ferrero, Paul D. van Poelje, David L. Linemeyer and Mark D. Erion
Drug Metabolism and Disposition November 2008, 36 (11) 2393-2403; DOI: https://doi.org/10.1124/dmd.108.021642
James M. Fujitaki
Edward E. Cable
Bruce R. Ito
Bao-Hong Zhang
Jinzhao Hou
Chun Yang
David A. Bullough
James L. Ferrero
Paul D. van Poelje
David L. Linemeyer
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Preclinical Pharmacokinetics of a HepDirect Prodrug of a Novel Phosphonate-Containing Thyroid Hormone Receptor Agonist
James M. Fujitaki, Edward E. Cable, Bruce R. Ito, Bao-Hong Zhang, Jinzhao Hou, Chun Yang, David A. Bullough, James L. Ferrero, Paul D. van Poelje, David L. Linemeyer and Mark D. Erion
Drug Metabolism and Disposition November 1, 2008, 36 (11) 2393-2403; DOI: https://doi.org/10.1124/dmd.108.021642
Research ArticleArticle
Preclinical Pharmacokinetics of a HepDirect Prodrug of a Novel Phosphonate-Containing Thyroid Hormone Receptor Agonist
James M. Fujitaki, Edward E. Cable, Bruce R. Ito, Bao-Hong Zhang, Jinzhao Hou, Chun Yang, David A. Bullough, James L. Ferrero, Paul D. van Poelje, David L. Linemeyer and Mark D. Erion
Drug Metabolism and Disposition November 1, 2008, 36 (11) 2393-2403; DOI: https://doi.org/10.1124/dmd.108.021642
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement